SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-022803
Filing Date
2021-11-10
Accepted
2021-11-10 16:07:42
Documents
70
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tpst-20210930.htm   iXBRL 10-Q 1704967
2 EX-31.1 exhibit311.htm EX-31.1 9658
3 EX-31.2 exhibit312.htm EX-31.2 9585
4 EX-32.1 exhibit321.htm EX-32.1 6941
  Complete submission text file 0001628280-21-022803.txt   6402920

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpst-20210930.xsd EX-101.SCH 45495
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpst-20210930_cal.xml EX-101.CAL 52434
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpst-20210930_def.xml EX-101.DEF 185666
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tpst-20210930_lab.xml EX-101.LAB 531042
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpst-20210930_pre.xml EX-101.PRE 346056
10 EXTRACTED XBRL INSTANCE DOCUMENT tpst-20210930_htm.xml XML 886483
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35890 | Film No.: 211396593
SIC: 2834 Pharmaceutical Preparations